 Pyruvate (PYR) supplementation protects myocardium ischemia reperfusion injury. study designed characterize quantify mechanism underlying protection: specifically whether ability resides PYR's metabolic effect antioxidant effect. Isolated perfused rat hearts (n = 6/group) subjected 15 min equilibration (EQ), 25 min ischemia, 10 min reperfusion (RP). Glucose sole metabolic substrate (Control) supplemented PYR (5 mM) (a) EQ (PYREQ group), (b) RP (PYRRP group), (c) EQ RP (PYREQ-RP group). Left ventricular developed pressure (DP) +/- dP/dt recorded throughout experiment. ATP concentrations intracellular pH determined 31P NMR spectroscopy. Myocardial creatinine kinase (CK) activity assayed end EQ end RP. vitro, purified CK assayed and, exposure H2O2 (200 microM) increasing concentrations PYR (0-6 mM) 10 min, reassayed determine antioxidant effect PYR. cases PYR improved recovery mechanical function end RP (DP: Control, 11 +/- 1%; PRYRP, 23 +/- 6%; PYREQ, 34 +/- 8%; PRYEQ&RP, 53 +/- 7%; P < 0.05 groups Control). Ischemic contracture delayed hearts received PYR EQ (PYREQ PYREQ&RP: 17.8 +/- 0.2 vs 12.5 +/- 0.3 min, P < 0.001). PYR EQ (PYREQ PYREQ&RP) led higher end ischemic ATP levels (32 +/- 4% vs 14 +/- 3%, P < 0.001) acidic end ischemic pH (5.92 +/- 0.02 vs 5.98 +/- 0.03 Control PYRRP, P < 0.05). PYREQ&RP showed highest end reperfusion ATP levels (55 +/- 7% vs 38 +/- 4%, P < 0.05 vs groups).(ABSTRACT TRUNCATED 250 WORDS)